Activin and Hepatocyte Growth Factor Promotes Colorectal Cancer Stemness and Metastasis through FOXM1/SOX2/CXCR4 Signaling
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Cancer stem cells (CSCs) are believed to drive tumor development and metastasis. Activin and hepatocyte growth factor (HGF) are important cytokines with the ability to induce cancer stemness. However, the effect of activin and HGF combination treatment on CSCs is still unclear. Methods: In this study, we sequentially treated colorectal cancer cells with activin and HGF and examined CSC marker expression, self-renewal, tumorigenesis, and metastasis. The roles of forkhead box M1 (FOXM1) and sex-determining region Y-box 2 (SOX2), two stemness-related transcription factors, in activin/HGF-induced aggressive phenotype were explored. Results: Activin and HGF treatment increased the expression of CSC markers and enhanced sphere formation in colorectal cancer cells. The tumorigenic and metastatic capacities of colorectal cancer cells were enhanced upon activin and HGF treatment. Activin and HGF treatment preferentially promoted stemness and metastasis of CD133+ subpopulations sorted from colorectal cancer cells. FOXM1 was upregulated by activin and HGF treatment, and the knockdown of FOXM1 blocked activin/HGF-induced stemness, tumorigenesis, and metastasis of colorectal cancer cells. Similarly, SOX2 was silencing impaired sphere formation of activin/HGF-treated colorectal cancers. Overexpression of SOX2 rescued the stem cell-like phenotype in FOXM1-depleted colorectal cancer cells with activin and HGF treatment. Additionally, the inhibition of FOXM1 via thiostrepton suppressed activin/HGF-induced stemness, tumorigenesis and metastasis. Conclusions: Sequential treatment with activin and HGF promotes colorectal cancer stemness and metastasis through activation of the FOXM1/SOX2 signaling. FOXM1 could be a potential target for the treatment of colorectal cancer metastasis.
Abstract
Background/Aims: Cancer stem cells (CSCs) are believed to drive tumor development and metastasis. Activin and hepatocyte growth factor (HGF) are important cytokines with the ability to induce cancer stemness. However, the effect of activin and HGF combination treatment on CSCs is still unclear. Methods: In this study, we sequentially treated colorectal cancer cells with activin and HGF and examined CSC marker expression, self-renewal, tumorigenesis, and metastasis. The roles of forkhead box M1 (FOXM1) and sex-determining region Y-box 2 (SOX2), two stemness-related transcription factors, in activin/HGF-induced aggressive phenotype were explored. Results: Activin and HGF treatment increased the expression of CSC markers and enhanced sphere formation in colorectal cancer cells. The tumorigenic and metastatic capacities of colorectal cancer cells were enhanced upon activin and HGF treatment. Activin and HGF treatment preferentially promoted stemness and metastasis of CD133+ subpopulations sorted from colorectal cancer cells. FOXM1 was upregulated by activin and HGF treatment, and the knockdown of FOXM1 blocked activin/HGF-induced stemness, tumorigenesis, and metastasis of colorectal cancer cells. Similarly, SOX2 was silencing impaired sphere formation of activin/HGF-treated colorectal cancers. Overexpression of SOX2 rescued the stem cell-like phenotype in FOXM1-depleted colorectal cancer cells with activin and HGF treatment. Additionally, the inhibition of FOXM1 via thiostrepton suppressed activin/HGF-induced stemness, tumorigenesis and metastasis. Conclusions: Sequential treatment with activin and HGF promotes colorectal cancer stemness and metastasis through activation of the FOXM1/SOX2 signaling. FOXM1 could be a potential target for the treatment of colorectal cancer metastasis.
참고문헌 (32)
- Fumagalli A, "Plasticity of Lgr5-negative cancer cells drives metastasis in colorectal cancer", Cell Stem Cell, 26, pp.569~578 (2020)
- Fujishita T, "The cAMP", PKA, SMAD4 pathways regulate stemness and metastatic potential in colorectal cancer cells, pp.Cancer Res, 2022[DOI]
- Lamichhane A, "Therapeutic targeting of cancer stem cells prevents resistance of colorectal cancer cells to MEK inhibition", ACS Pharmacol Transl Sci, 5, pp.724~734 (2022)
- Hirata A, "Heterogeneity in colorectal cancer stem cells", Cancer Prev Res(Phila), 12, pp.413~420 (2019)
- Zhang X, "Single-cell sequencing reveals CD133+CD44--originating evolution and novel stemness related variants in human colorectal cancer", EBioMedicine, 82, pp.104125~ (2022)
- Kim J, "Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival", J Clin Oncol, 23, pp.2744~2753 (2005)
- Zhang SS, "CD133(+)CXCR4(+)colon cancer cells exhibit metastatic potential and predict poor prognosis of patients", BMC Med, 10, pp.85~ (2012)
- Madhi H, "FOXM1 inhibition enhances the therapeutic outcome of lung cancer immunotherapy by modulating PD-L1 expression and cell proliferation", Adv Sci(Weinh), 9, pp.e2202702~ (2022)
- Kohata M, "Roles of FoxM1-driven basal β-cell proliferation in maintenance of β-cell mass and glucose tolerance during adulthood", J Diabetes Investig, 13, pp.1666~1676 (2022)
- Weng W, "FOXM1 and FOXQ1 are promising prognostic biomarkers and novel targets of tumor-suppressive mir-342in human colorectal cancer", Clin Cancer Res, 22, pp.4947~4957 (2016)
- Sher G, "Dysregulated FOXM1 signaling in the regulation of cancer stem cells", Semin Cancer Biol, 86(Pt 3), pp.107~121 (2022)
- Yuan B, "FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness", Cell Death Dis, 9, pp.562~ (2018)
- Song IS, "FOXM1-induced PRX3regulates stemness and survival of colon cancer cells via maintenance of mitochondrial function", Gastroenterology, 149, pp.1006~1016 (2015)
- Perkhofer L, "Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin", nodal-dependent induction of stemness, 2016, pp.17, 367~378
- Zhu L, "Crosstalk between bone marrow-derived myofibroblasts and gastric cancer cells regulates cancer stemness and promotes tumorigenesis", Oncogene, 35, pp.5388~5399 (2016)
- Vermeulen L, "Wnt activity defines colon cancer stem cells and is regulated by the microenvironment", Nat Cell Biol, 12, pp.468~476 (2010)
- Hay DC, "Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vivo", Stem Cells, 26, pp.894~902 (2008)
- Peng H, "Sequential treatment with activin and hepatocyte growth factor induces FOXM1 to promote colorectal cancer liver metastasis", Can J Gastroenterol Hepatol, 2022, pp.8996203~ (2022)
- Daitoku N, "Activin A promotes cell proliferation, invasion and migration and predicts poor prognosis in patients with colorectal cancer", Oncol Rep, 47, pp.107~ (2022)
- Joosten SP, "Hepatocyte growth factor", MET and CD44 in colorectal cancer : partners in tumorigenesis and therapy resistance, 2020, pp.1874, 188437~
- Takata A, "Direct differentiation of hepatic cells from human induced pluripotent stem cells using a limited number of cytokines", Hepatol Int, 5, pp.890~898 (2011)
- Mamun MA, "SOX2 in cancer stemness : tumor malignancy and therapeutic potentials", J Mol Cell Biol, 12, pp.85~98 (2020)
- Liu H, "Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis", Cell Death Differ, 27, pp.966~983 (2020)
- Ottaviani S, "TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression", Nat Commun, 9, pp.1845~ (2018)
- Xiao L, "Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells", Stem Cells, 24, pp.1476~1486 (2006)
- Wang B, "SDF-1", CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin αvβ6, 2014, pp.35, 282~291
- Xu P, "The abnormal expression of circ-ARAP2 promotes ESCC progression through regulating miR-761", FOXM1 axis-mediated stemness and the endothelial-mesenchymal transition, 2022, pp.20, 318~
- Sun HL, "FOXM1 facilitates breast cancer cell stemness and migration in YAP1-dependent manner", Arch Biochem Biophys, 685, pp.108349~ (2020)
- Zhao N, "SOX2 maintains the stemness of retinoblastoma stem-like cells through Hippo", YAP signaling pathway, 2022, pp.214, 108887~
- Chang TY, "ANGPTL1attenuates cancer migration, invasion, and stemness through regulating FOXO3a-mediated SOX2 expression in colorectal cancer", Clin Sci(Lond), 136, pp.657~673 (2022)
- Zhu Y, "SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1", autophagy signaling in colorectal cancer, 2021, pp.12, 449~
- Iida H, "Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3", 4 and SOX2, 2012, pp.40, 71~79